Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups

Background Remimazolam is a new ultra short-acting benzodiazepine originally developed as an improved version of midazolam. Recent studies have demonstrated non-inferiority of remimazolam to propofol in general anesthesia. However, to date, few studies have investigated the induction bolus dose of r...

Full description

Bibliographic Details
Main Authors: Juyeon Oh, Sung Yong Park, Sook Young Lee, Ju Yeol Song, Ga Yun Lee, Ji Hyun Park, Han Bum Joe
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2022-12-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kja-22331.pdf
_version_ 1828097913002131456
author Juyeon Oh
Sung Yong Park
Sook Young Lee
Ju Yeol Song
Ga Yun Lee
Ji Hyun Park
Han Bum Joe
author_facet Juyeon Oh
Sung Yong Park
Sook Young Lee
Ju Yeol Song
Ga Yun Lee
Ji Hyun Park
Han Bum Joe
author_sort Juyeon Oh
collection DOAJ
description Background Remimazolam is a new ultra short-acting benzodiazepine originally developed as an improved version of midazolam. Recent studies have demonstrated non-inferiority of remimazolam to propofol in general anesthesia. However, to date, few studies have investigated the induction bolus dose of remimazolam required to achieve general anesthesia. We aimed to determine the 95% effective dose (ED95) of remimazolam bolus required to achieve loss of consciousness (LOC) and the appropriate doses for different age groups. Methods Patients aged 20–79 years with the American Society of Anesthesiologists physical status of I or II were enrolled in this study. A total of 120 patients were included representing young, middle-aged, and elderly groups. Loss of eyelash reflex and verbal response after the administration of remimazolam was considered successful LOC. The ED95 of remimazolam was determined using a biased coin up-and-down design with sequential allocation and the isotonic regression method. Results The ED95 of remimazolam for induction of general anesthesia was 0.367 mg/kg (95% CI [0.277, 0.392]) in the young group, 0.369 mg/kg (95% CI [0.266, 0.394]) in the middle-aged group, and 0.249 mg/kg (95% CI [0.199, 0.288]) in the elderly group. During the study period, none of the patients required rescue medications for hypotension or bradycardia. Conclusions This study investigated the ED95 of remimazolam bolus for anesthesia induction. The precise dosing of the ED95 can help maintain hemodynamic stability during the induction of anesthesia.
first_indexed 2024-04-11T07:53:26Z
format Article
id doaj.art-1b3be443692d40eaa786a25221c00aad
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-04-11T07:53:26Z
publishDate 2022-12-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-1b3be443692d40eaa786a25221c00aad2022-12-22T04:35:59ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632022-12-0175651051710.4097/kja.223318828Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groupsJuyeon Oh0Sung Yong Park1Sook Young Lee2Ju Yeol Song3Ga Yun Lee4Ji Hyun Park5Han Bum Joe6 Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Korea Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Korea Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Korea Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Korea Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Korea Office of Biostatics, Medical Research Collaborating Center, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Korea Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, KoreaBackground Remimazolam is a new ultra short-acting benzodiazepine originally developed as an improved version of midazolam. Recent studies have demonstrated non-inferiority of remimazolam to propofol in general anesthesia. However, to date, few studies have investigated the induction bolus dose of remimazolam required to achieve general anesthesia. We aimed to determine the 95% effective dose (ED95) of remimazolam bolus required to achieve loss of consciousness (LOC) and the appropriate doses for different age groups. Methods Patients aged 20–79 years with the American Society of Anesthesiologists physical status of I or II were enrolled in this study. A total of 120 patients were included representing young, middle-aged, and elderly groups. Loss of eyelash reflex and verbal response after the administration of remimazolam was considered successful LOC. The ED95 of remimazolam was determined using a biased coin up-and-down design with sequential allocation and the isotonic regression method. Results The ED95 of remimazolam for induction of general anesthesia was 0.367 mg/kg (95% CI [0.277, 0.392]) in the young group, 0.369 mg/kg (95% CI [0.266, 0.394]) in the middle-aged group, and 0.249 mg/kg (95% CI [0.199, 0.288]) in the elderly group. During the study period, none of the patients required rescue medications for hypotension or bradycardia. Conclusions This study investigated the ED95 of remimazolam bolus for anesthesia induction. The precise dosing of the ED95 can help maintain hemodynamic stability during the induction of anesthesia.http://ekja.org/upload/pdf/kja-22331.pdfgeneral anesthesiahypnotics and sedativesintravenous anesthesiaremimazolamunconsciousnessvital signs
spellingShingle Juyeon Oh
Sung Yong Park
Sook Young Lee
Ju Yeol Song
Ga Yun Lee
Ji Hyun Park
Han Bum Joe
Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
Korean Journal of Anesthesiology
general anesthesia
hypnotics and sedatives
intravenous anesthesia
remimazolam
unconsciousness
vital signs
title Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
title_full Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
title_fullStr Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
title_full_unstemmed Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
title_short Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
title_sort determination of the 95 effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
topic general anesthesia
hypnotics and sedatives
intravenous anesthesia
remimazolam
unconsciousness
vital signs
url http://ekja.org/upload/pdf/kja-22331.pdf
work_keys_str_mv AT juyeonoh determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups
AT sungyongpark determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups
AT sookyounglee determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups
AT juyeolsong determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups
AT gayunlee determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups
AT jihyunpark determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups
AT hanbumjoe determinationofthe95effectivedoseofremimazolamtoachievelossofconsciousnessduringanesthesiainductionindifferentagegroups